| Occurrence of vertebrate steroids, estradiol 17β and progesterone in the reproducing females of the mud crab Scylla serrata SR Warrier, R Tirumalai, T Subramoniam Comparative Biochemistry and Physiology Part A: Molecular & Integrative …, 2001 | 116 | 2001 |
| Secreted frizzled related proteins: Implications in cancers R Surana, S Sikka, W Cai, EM Shin, SR Warrier, HJG Tan, F Arfuso, ... Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1845 (1), 53-65, 2014 | 110 | 2014 |
| Potential role of natural compounds as anti-angiogenic agents in cancer MK Shanmugam, S Warrier, AP Kumar, G Sethi, F Arfuso Current vascular pharmacology 15 (6), 503-519, 2017 | 96 | 2017 |
| Cancer stem-like cells from head and neck cancers are chemosensitized by the Wnt antagonist, sFRP4, by inducing apoptosis, decreasing stemness, drug resistance and epithelial … S Warrier, G Bhuvanalakshmi, F Arfuso, G Rajan, M Millward, ... Cancer gene therapy 21 (9), 381-388, 2014 | 80 | 2014 |
| Receptor mediated yolk protein uptake in the crab Scylla serrata: crustacean vitellogenin receptor recognizes related mammalian serum lipoproteins S Warrier, T Subramoniam Molecular reproduction and development 61 (4), 536-548, 2002 | 67 | 2002 |
| Pro-apoptotic and anti-cancer properties of diosgenin: A comprehensive and critical review G Sethi, MK Shanmugam, S Warrier, M Merarchi, F Arfuso, AP Kumar, ... Nutrients 10 (5), 645, 2018 | 66 | 2018 |
| Wnt antagonist, secreted frizzled-related protein 4 (sFRP4), increases chemotherapeutic response of glioma stem-like cells S Warrier, SK Balu, AP Kumar, M Millward, A Dharmarajan Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 21 …, 2014 | 52 | 2014 |
| Secreted frizzled-related protein 4 inhibits glioma stem-like cells by reversing epithelial to mesenchymal transition, inducing apoptosis and decreasing cancer stem cell properties F Arfuso, M Millward, A Dharmarajan, S Warrier PloS one 10 (6), e0127517, 2015 | 50 | 2015 |
| Breast cancer stem-like cells are inhibited by diosgenin, a steroidal saponin, by the attenuation of the Wnt β-catenin signaling via the Wnt antagonist secreted frizzled … G Bhuvanalakshmi, KS Rangappa, A Dharmarajan, G Sethi, AP Kumar, ... Frontiers in Pharmacology 8, 124, 2017 | 46 | 2017 |
| Role of novel histone modifications in cancer MK Shanmugam, F Arfuso, S Arumugam, A Chinnathambi, B Jinsong, ... Oncotarget 9 (13), 11414, 2018 | 44 | 2018 |
| Inherent propensity of amnion-derived mesenchymal stem cells towards endothelial lineage: vascularization from an avascular tissue S Warrier, N Haridas, R Bhonde Placenta 33 (10), 850-858, 2012 | 39 | 2012 |
| Epigenetic regulation of the secreted frizzled-related protein family in human glioblastoma multiforme L Schiefer, M Visweswaran, V Perumal, F Arfuso, D Groth, P Newsholme, ... Cancer gene therapy 21 (7), 297-303, 2014 | 37 | 2014 |
| Study of chemoresistant CD133+ cancer stem cells from human glioblastoma cell line U138MG using multiple assays S Warrier, P Pavanram, D Raina, M Arvind Cell biology international 36 (12), 1137-1143, 2012 | 32 | 2012 |
| ‘Lnc’‐ing Wnt in female reproductive cancers: therapeutic potential of long non‐coding RNAs in Wnt signalling MS Ong, W Cai, Y Yuan, HC Leong, TZ Tan, A Mohammad, ML You, ... British Journal of Pharmacology 174 (24), 4684-4700, 2017 | 25 | 2017 |
| The expanding roles of long non-coding RNAs in the regulation of cancer stem cells Z Ma, YY Wang, HW Xin, L Wang, F Arfuso, A Dharmarajan, AP Kumar, ... The International Journal of Biochemistry & Cell Biology 108, 17-20, 2019 | 19 | 2019 |
| Epigenetic reprogramming converts human Wharton’s jelly mesenchymal stem cells into functional cardiomyocytes by differential regulation of Wnt mediators G Bhuvanalakshmi, F Arfuso, AP Kumar, A Dharmarajan, S Warrier Stem cell research & therapy 8 (1), 1-15, 2017 | 18 | 2017 |
| A synthetic formulation, Dhanwantharam kashaya, delays senescence in stem cells. AD S R Warrier, N Haridas, S Balasubramanian, A Jalisatgi, R Bhonde Cell Proliferation 46 (3), 283-90, 2013 | 15 | 2013 |
| Encapsulated human mesenchymal stem cells (eMSCs) as a novel anti-cancer agent targeting breast cancer stem cells: Development of 3D primed therapeutic MSCs S Mandal, F Arfuso, G Sethi, A Dharmarajan, S Warrier The international journal of biochemistry & cell biology 110, 59-69, 2019 | 14 | 2019 |
| Aberrant lipid metabolism as an emerging therapeutic strategy to target cancer stem cells M Visweswaran, F Arfuso, S Warrier, A Dharmarajan Stem Cells 38 (1), 6-14, 2020 | 13 | 2020 |
| Stemness, pluripotentiality, and Wnt antagonism: sFRP4, a Wnt antagonist mediates pluripotency and stemness in glioblastoma G Bhuvanalakshmi, N Gamit, M Patil, F Arfuso, G Sethi, A Dharmarajan, ... Cancers 11 (1), 25, 2019 | 13 | 2019 |
Frank ArfusoAdjunct Research Fellow, Stem Cell and Cancer Biology Laboratory, School of Biomedical SciencesVerified email at curtin.edu.au
